Under the arrangement, Ranbaxy will market Cravit (levofloxacin), the synthetic antibacterial agent originally discovered by Daiichi Sankyo, in Malaysia from January 01, 2012. The product is currently commercialized by First Pharmaceutical Sdn. Bhd.
Henan Kangtai Pharmaceutical Co., Ltd.
Norfloxacin|Norfloxacin HCL|Norfloxacin Nicotinate|Norfloxacin Lactate|Pefloxacin Mesylate|Mitomycin C|